Logo-bi
Review
Sepideh Zununi Vahed, Mohammadreza Ardalan, Nasser Samadi, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(1): 45-54. doi: 10.15171/bi.2015.12
PMCID: PMC4401167     PMID: 25901296     Scopus ID: 84924854767    
Original Research
Sina Raeisi, Amir Ghorbanihaghjo*, Hassan Argani, Siavoush Dastmalchi, Babollah Ghasemi, Teimour Ghazizadeh, Nadereh Rashtchizadeh, Mehran Mesgari Abbasi, Nasrin Bargahi, Mahboob Nemati, Ali Mota, Amir Mansour Vatankhah
Bioimpacts. 2016;6(3): 119-124. doi: 10.15171/bi.2016.18
PMCID: PMC5108984     PMID: 27853675     Scopus ID: 85003976973    
Original Research
Fatemeh Sanie-Jahromi ORCID, Masoomeh Eghtedari, Esmaeil Mirzaei, Mohammad Hassan Jalalpour, Zahra Asvar, Mahmood Nejabat* ORCID, Fahimeh Javidi-Azad
Bioimpacts. 2020;10(1): 45-54. doi: 10.15171/bi.2020.06
PMCID: PMC6977591     PMID: 31988856     Scopus ID: 85078977726    
The represented data indicated the priority of PCL/Gel for LESC attachment, proliferation and transplantation in animal models.
Original Research
Mohammad A. Rafi ORCID, Paola Luzi, David A. Wenger* ORCID
Bioimpacts. 2020;10(2): 105-115. doi: 10.34172/bi.2020.13
PMCID: PMC7186542     PMID: 32363154     Scopus ID: 85090729388    
Krabbe disease (KD) is an autosomal recessive lysosomal disorder that imposes defective myelination in the peripheral and central nervous systems. Twitcher combining bone marrow transplantation with AAVrh10-mGALC can have a great extension of life in the murine model of KD.
Original Research
Mohammad A Rafi* ORCID, Paola Luzi, David A Wenger ORCID
BioImpacts. 2021;11(2): 135-146. doi: 10.34172/bi.2021.21
PMCID: PMC8022232     PMID: 33842284     Scopus ID: 85106877684    
Our results demonstrate that, it may be possible to treat human KD patients with high dose AAVrh10 without blood stem cell transplantation which would eliminate the side effects of HSCT.
Mini Review
Mohammad A. Rafi* ORCID
Bioimpacts. 2022;12(1): 3-7. doi: 10.34172/bi.2021.23931
PMCID: PMC8783082     PMID: 35087711     Scopus ID: 85127157009    
Cutting viral dose in half or using BM cells from heterozygote mice in a combination of BMT and gene therapy treatments result in a similar reduction in lifespan of the treated mice.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge